Mixed Asian Americans and Health: Navigating Uncharted Waters

Posted in Asian Diaspora, Books, Chapter, Health/Medicine/Genetics, Identity Development/Psychology, Media Archive, United States on 2013-01-19 02:11Z by Steven

Mixed Asian Americans and Health: Navigating Uncharted Waters

Chapter in: Handbook of Asian American Health

Springer
2013
pages 129-134
Print ISBN: 978-1-4614-2226-6
eBook ISBN: 978-1-4614-2227-3
DOI: 10.1007/978-1-4614-2227-3

Edited by:

Grace J. Yoo
San Francisco State University
 
Mai-Nhung Le
San Francisco State University

Alan Y. Oda
Azusa Pacific University, Azusa, California

Chapter Author:

Cathy J. Tashiro, PhD, RN, Associate Professor of Nursing
University of Washington, Tacoma

Over 2.6 million people who self-identified with more than one race in the 2010 U.S. Census claimed Asian ancestry, about 15% of the total population of Asians, making these individuals a significant part of Asian America. Mixed Asian Americans come from a variety of backgrounds, making it difficult to generalize about their health, though some common characteristics have emerged. While research on physical health outcomes of mixed Asian Americans is still limited, there is a growing body of research that may indicate increased risk for behavioral problems among some subgroups. The chapter reviews the existing research and discusses social and genetic factors relevant to the health and wellbeing of mixed Asian Americans.

Introduction

What are the health implications of being a mixed Asian American? Very little is known about this diverse and rapidly expanding population. The little we do know is complicated by the collision between biological concepts of “race” and the social process of racial categorization. Asian America includes such diverse populations that it’s difficult to make biological generalizations about them. Yet there are some well-established differences between certain Asian groups and the majority population that have important health implications. Two examples will be discussed in this chapter. For people of mixed Asian ancestry who may also have ancestral roots in Europe, Africa, and/or the Americas, the complexities of possible combinations and their implications are daunting. But there is an urgent need to tease apart the social and biological meanings of being a mixed Asian American. Researchers whose studies are discussed in this chapter are beginning to do this important work. Hopefully, in the near future, a mixed Asian American confronted with health risks by race who asks “But what does this mean for me?” will find real answers…

Tags: , ,

When should medicine talk about race?

Posted in Articles, Health/Medicine/Genetics, Media Archive on 2013-01-19 00:39Z by Steven

When should medicine talk about race?

Scientific American
Unofficial Prognosis: Perceptions and prescriptions of a medical student
2012-08-25

Ilana Yurkiewicz
Harvard Medical School

Race is everywhere in medicine. Most health statistics are broken down by race. We routinely characterize diseases by which populations they affect more and less and medications by which ethnicities respond better or worse.
 
It’s so ubiquitous that it’s easy to take for granted as justified. But the use of race in medicine is a subject that is vigorously debated. Whenever a new study comes out stratifying results by race, there are inevitably supporters and critics.
 
The question under debate: is there a place for race in medicine?

There’s a growing number who say we should toss this way of thinking entirely. Many scholars now contend that race is closer to a social construct than a biological category, and there’s the legitimate fear that pointing out differences between races sends the message that the difference is biological. Even if there are certain genetic differences among populations, we know that self-reported race is at best a crude proxy for indicating them. Moreover, studies often do not adjust for all other variables besides genetics, such as socioeconomic status, culture, and discrimination – meaning if differences are shown, the knee-jerk tendency to think biology might overshadow important environmental disparities that deserve our attention. There are social concerns too, in that historically ethnicity in research has been abused by pseudoscientists with racist agendas of demonstrating the superiority of certain people over others. In light of that history, profound sensitivity toward using race as a variable in medicine is understandable and warranted…

…When comparing groups, we can draw the lines wherever we want. Telling of this point is that many studies that talk about race still only compare blacks to whites, ignoring all other groups along with cases of mixed ancestry…

Read the entire article here.

Tags: ,

Study Links Highly Segregated Counties and Lung Cancer Deaths in Blacks

Posted in Articles, Health/Medicine/Genetics, New Media, United States on 2013-01-16 23:41Z by Steven

Study Links Highly Segregated Counties and Lung Cancer Deaths in Blacks

The New York Times
2013-01-16

Sabrina Tavernise

African-Americans who live in highly segregated counties are considerably more likely to die from lung cancer than those in counties that are less segregated, a new study has found.

The study was the first to look at segregation as a factor in lung cancer mortality. Its authors said they could not fully explain why it worsens the odds of survival for African-Americans, but hypothesized that blacks in more segregated areas may be less likely to have health insurance or access to health care and specialty doctors. It is also possible that lower levels of education mean they are less likely to seek care early, when medical treatment could make a big difference. Racial bias in the health care system might also be a factor…

Dr. David Chang, director of outcomes research at the University of California San Diego Department of Surgery, who wrote an accompanying editorial, said he hoped that the study would focus attention on the environmental factors involved in the stark disparities in health outcomes in the United States because they lend themselves to change through policy. Medical researchers tend to focus on factors like the genetics and the behaviors of individuals that are harder to change.

“We don’t need drugs or genetic explanations to fix a lot of the health care problems we have,” he said.

Read the entire article here.

Tags: , , , ,

The End of Race History? Not Yet

Posted in Articles, Health/Medicine/Genetics, Media Archive on 2013-01-15 01:29Z by Steven

The End of Race History? Not Yet

Center for Genetics and Society
2012-12-14

Osagie K. Obasogie, Associate Professor of Law
University of California, Hastings

Have we gone beyond race? Many argue society has now overcome centuries of strife to become “post-racial”—a moment that law professor Sumi Cho of DePaul University in Chicago refers to as “the end of race history”.

Two seemingly disparate developments have been used to lend support to this claim. In politics, Barack Obama’s 2008 election as the first racial minority-member to become US president has been lauded as a racially transcendent moment. In science, the completion of the Human Genome Project’s first draft in June 2000 offered seemingly definitive evidence that race is not real. As geneticist Craig Venter noted at the HGP announcement, “the concept of race has no genetic or scientific basis”…

…Two recent books by legal scholars address these issues. Jonathan Kahn’s Race in a Bottle provides a stunning case study of BiDil, the first drug to receive approval by the US Food and Drug Administration as a race-specific therapy. It was designed to treat African-Americans suffering from heart failure—based mainly on a mistaken belief that there are meaningful disparities in heart failure outcomes between blacks and whites caused by biological differences. Although BiDil was initially created as a race-neutral drug, Kahn offers a compelling account of the many influences that turned what is in essence a combination therapy of two widely available generic treatments into a pill “for black people only”…

Dorothy Roberts’s Fatal Invention, now out in paperback, extends this insight to examine how the re-emergence of biological race is having a broader impact—not only on innovations such as genetic ancestry-testing and racialised aspects of DNA forensics, but also on how we think about basic notions of racial difference. Advocates of biological race argue that today’s use of race in biomedicine is different from past usages within science that supported racism, eugenics and questionable research practices…

Read the entire article here.

Tags: , , , , , ,

Biracial women pushed to undergo genetic screeening: Cobble Hill hospital focuses on mixed race

Posted in Articles, Health/Medicine/Genetics, Media Archive, United States on 2013-01-14 17:32Z by Steven

Biracial women pushed to undergo genetic screeening: Cobble Hill hospital focuses on mixed race

New York Daily News
2013-01-13

Simone Weichselbaum

As interracial families become more common, LICH docs quiz women on ethnicity

Doctors are pushing biracial Brooklyn women to undergo genetic counseling to learn if their racial mix makes them more prone to disease.
 
As interracial families have beome more common, Dr. Millicent Comrie, Chief of Obstetrics and Gynecology at Downstate Long Island College Hospital, has urged her staff of about 40 physicians to quiz patients about their ethnic backgrounds.
 
Those from multicultural backgrounds are are sent to talk with a DNA expert who maps out how their heritage could make them sick.
 
“Ethnicity plays a big part in your healthcare,” said Comrie naming a slew of hereditary diseases such as sickle cell anemia which plagues the black community and Tay-Sachs disease found in many Jewish families.
 
“We can’t worry about sensitivity when it comes to race. What you see isn’t always what you get,” Comrie said. “If we don’t ask the right questions. We will come up We will come up short.”…

Read the entire article here.

Tags: , ,

Funding Race as Biology: The Relevance of “Race” in Medical Research

Posted in Articles, Health/Medicine/Genetics, Media Archive, Politics/Public Policy, United States on 2013-01-08 22:04Z by Steven

Funding Race as Biology: The Relevance of “Race” in Medical Research

Minnesota Journal of Law, Science & Technology
Volume 12, Issue 2 (Spring 2011)
pages 571-618

Taunya Lovell Banks, Jacob A. France Professor of Equality Jurisprudence and Francis & Harriet Iglehart Research Professor of Law
University of Maryland School of Law

Note from Steven F. Riley: See the articles, “Fracture Risk Assessment without Race/Ethnicity Information,” and “Taking race out of the equation in measuring women’s risk of osteoporosis and fractures” about the positive results of taking “race” out of medicine.

I. INTRODUCTION: ‘DEM BONES, ‘DEM BONES, ‘DEM “BLACK” BONES

In 1940 the State of North Carolina classified my friend as “colored” despite her “white skin, blue eyes, [and] curling blond hair.” She—like her parents, grandparents, and many other black Americans—is often mistaken for white. Sixty years later when she went for a bone densitometry test—a must for postmenopausal women—the technician asked her to fill out a form that asked her race. Surprised, she asked why. The technician explained that “since the bones of black people are different than the bones of white people, the doctor needed this information to interpret the scan correctly.”

The radiologist who analyzed my friend’s bone scan acknowledged that there is a debate within the radiology community about the scientific validity of interpreting an X-ray through the lens of race. But, he claimed, it is impossible to interpret the bone scan without factoring in race because the machines that analyze the bone scan can only produce an analysis if the race of the person being analyzed is included. The doctor could not explain how the x-ray machine defined “race,” replying that the definitions “were created by the companies that built the machines.”

My friend asked if there was any way she could get more helpful advice about the condition of her bones. The radiologist thought for a moment, then suggested that perhaps my friend should have her bone densitometry test performed twice, once as “white,” then as “black.” The condition of her bones, he told her, would lie somewhere between the two results. However, my friend concluded that “one-half of a fantasy definition of ‘white’ plus one-half of a fantasy definition of ‘black’ will only yield one whole fantasy: it will not provide a sound medical diagnosis.”  Thus she marked “black” or “African American” because that had always been her legal and social identity. So what did the results really tell her doctor?

For years my friend taught and wrote about the social construction of race and knew that her doctor’s explanation about the use of race as a biological term by the radiology community was flawed. She found it reminiscent of the World War II era when the Nazis kept “separate blood banks for ‘Jewish blood’ and ‘Aryan blood,’ [and] American blood banks were separating ‘white blood’ and ‘black blood’.” The United States has a long and continuing history of “unconscionable medical research” involving black Americans.

In 1950 the United Nations Educational, Scientific and Cultural Organization (UNESCO), mindful of race-science’s dark and not so distant history, drafted a statement on the use of race in modern science. This statement, developed by an esteemed group of anthropologists, psychologists, and sociologists, concludes: “[f]or all practical social purposes ‘race’ is not so much a biological phenomenon as a [damaging] social myth.” Today most scientists agree that race and ethnicity (ethno-race) classifications are the result of social and political conditions, as opposed to biological differences. There is, however, disagreement about the scientific validity of these categories.

Even though an increasing number of scientists believe that too often ethno-race is used as a surrogate for various socioeconomic and environmental factors, for most of the late twentieth century social science and medical researchers continued to use ethno-race in a biological context.

Nevertheless, there are times when ethno-racial designations have value in medical research. As one scholar writes, “using race as a social category” to study the impact of racism on health and access to medical care is critical to eliminating health inequities based on race. But, she cautions that using race as a biological category can reflect and reinforce racial stratification as well as racist notions of inherent human difference. Several commentators call this phenomenon the reification of race, where the social concept of race is transformed “into a specific, definite, concrete, and now presumably genetic category which can feed back into preexisting lay understandings of racial difference.”…

…This article proceeds from the assumption that there are few clear instances, other than perhaps access to health care or measuring equality in medical treatment, where the use of ethno-race in medical research is appropriate. Even in those limited situations the justification for using ethno-race, how the ethno-racial categories are defined, and the method for assigning ethno-race warrant close scrutiny and oversight, especially when these studies are funded with federal money. In the next section, this article explains the scientific basis for that assertion. First, it explores the debates within the medical community about the connection between race and biology in biomedicine. Then it examines literature on race-related stress to determine whether this might be an instance where ethno-racial labels help explain health outcomes, and argues that guidelines or regulation are needed.

The third section of this article examines two sets of guidelines on the use of ethno-race in biomedical research: guidelines adopted by high impact medical journals, and federal guidelines on the use of ethno-race in federally funded biomedical research. Finding these measures inadequate, this article argues that the only way to quickly change research behavior in this area is through greater regulation and oversight of federal medical research grants. More stringent government regulation and oversight of federally funded biomedical research grants that use ethno-race may trigger changes in the medical culture faster than litigation.

In the fourth section this article proposes a regulatory scheme that offers a standard to measure the appropriateness of ethno-race in applications for federally funded biomedical research that will cause both researchers and grant reviewers to give more thought to how and why ethno-race is used in research protocols. This article concedes that this proposal is only a first step, and acknowledges that meaningful progress also requires strong and effective measures designed to change how biology is taught in undergraduate, graduate, and professional schools. But without a change in the medical culture, another generation of researchers and health care providers will be trained to think about ethno-racial differences inappropriately.

Before effective remedies for the problem described can be discussed, it is important to clarify both the meaning and use of the term “race” in scientific discussions. The next section of this paper looks at debates within the scientific community about the meaning of ethno-racial labels…

Read the entire article here.

Tags: , , ,

From Bang to Whimper: A Heart Drug’s Story

Posted in Articles, Book/Video Reviews, Health/Medicine/Genetics, Media Archive, United States on 2013-01-08 16:33Z by Steven

From Bang to Whimper: A Heart Drug’s Story

The New York Times
2012-12-24

Abigail Zuger, M.D.

Jonathan Kahn, Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age. Columbia University Press, December 2012, 336 pages.

On June 23, 2005, American medicine managed to take a small step forward and a giant step backward at precisely the same time, with government approval of the first medication to be earmarked for a specific racial group. It was BiDil, a drug designed to treat heart failure in blacks.

Enthusiasts hailed BiDil’s approval by the Food and Drug Administration as a landmark event in the nascent field of pharmacogenomics, which aims to create drugs tailored to fit an individual’s genetic makeup as precisely as a bespoke suit drapes its owner’s shoulders. Critics just winced and clocked one more misstep in medicine’s long history of race-related disasters.

You would think that the elucidation of the human genome would have cleared up most of the hoary untruths surrounding race and health. But as Jonathan Kahn makes clear in his worthy if convoluted review of the events surrounding the birth of BiDil, the genome has in many respects only made things worse.

It has been clear for decades that race has minimal relevance to the body’s inner workings. Research has repeatedly shown that the biologic variations among individuals of the same race are reliably great enough for race to retain little utility as a biologic predictor. You might as well sort people by height. Or, in the words of an editorial writer for Nature Biotechnology in 2005, “Pooling people in race silos is akin to zoologists grouping raccoons, tigers and okapis on the basis that they are all stripy.”

Read the entire review here.

Tags: , , , ,

How Personalized Medicine Became Genetic, and Racial: Werner Kalow and the Formations of Pharmacogenetics

Posted in Articles, Health/Medicine/Genetics, Media Archive on 2012-12-25 20:44Z by Steven

How Personalized Medicine Became Genetic, and Racial: Werner Kalow and the Formations of Pharmacogenetics

Journal of the History of Medicine and Allied Sciences
Volume 68, Number 1, January 2013
pages 1-48
DOI: 10.1093/jhmas/jrr046

David S. Jones, A. Bernard Ackerman Professor of the Culture of Medicine
Harvard University

Physicians have long puzzled over a well-known phenomenon: different patients respond differently to the same treatment. Although many explanations exist, pharmacogenetics has now captured the medical imagination. While this might seem part of the broader interest in all things genetic, the early history of pharmacogenetics reveals the specific factors that contributed to the emergence of genetics within pharmacology. This paper examines the work of one pioneering pharmacologist, Werner Kalow, to trace the evolving intellectual formations of pharmacogenetics and, in particular, the focus on race. Working in the 1950s and 1960s, Kalow made three arguments to demonstrate the relevance of genetics to pharmacology, based on laboratory techniques, analogies to differences between other animal species, and appeals to the logic of natural selection. After contributing to the emergence of the field, Kalow maintained his advocacy for pharmacogenetics for four decades, collecting more evidence for its relevance, navigating controversies about race and science, and balancing genetics against other possible explanations of patient variability. Kalow’s work demonstrates the deep roots of the genetic and racial preoccupations in pharmacology. Understanding this history can restore attention to other explanations of individuality in medical practice, something of increasing importance given the current interest in personalized medicine.

Read the entire article here.

Tags: , , ,

Medicating Race: Heart Disease and Durable Preoccupations with Difference

Posted in Books, Health/Medicine/Genetics, Media Archive, Monographs, Politics/Public Policy, United States on 2012-12-22 19:05Z by Steven

Medicating Race: Heart Disease and Durable Preoccupations with Difference

Duke University Press
October 2012
280 pages
5 illustrations
Paperback ISBN: 978-0-8223-5344-7
Cloth ISBN: 978-0-8223-5329-4

Anne Pollock, Assistant Professor of Science, Technology and Culture
Georgia Institute of Technology, Atlanta, Georgia

In Medicating Race, Anne Pollock traces the intersecting discourses of race, pharmaceuticals, and heart disease in the United States over the past century, from the founding of cardiology through the FDA’s approval of BiDil, the first drug sanctioned for use in a specific race. She examines wide-ranging aspects of the dynamic interplay of race and heart disease: articulations, among the founders of American cardiology, of heart disease as a modern, and therefore white, illness; constructions of “normal” populations in epidemiological research, including the influential Framingham Heart Study; debates about the distinctiveness African American hypertension, which turn on disparate yet intersecting arguments about genetic legacies of slavery and the comparative efficacy of generic drugs; and physician advocacy for the urgent needs of black patients on professional, scientific, and social justice grounds. Ultimately, Pollock insists that those grappling with the meaning of racialized medical technologies must consider not only the troubled history of race and biomedicine but also its fraught yet vital present. Medical treatment should be seen as a site of, rather than an alternative to, political and social contestation. The aim of scholarly analysis should not be to settle matters of race and genetics, but to hold medicine more broadly accountable to truth and justice.

Table of Contents

  • Acknowledgments
  • Introduction
  • 1. Racial Preoccupations and Early Cardiology
  • 2. Making Normal Populations and Making Difference in the Framingham and Jackson Heart Studies
  • 3. The Durability of African American Hypertension as a Disease Category
  • 4. The Slavery Hypothesis beyond Genetic Determinism
  • 5. Thiazide Diuretics as a Nexus of Associations: Racialized, Proven, Old, Cheap
  • 6. BiDil: Medicating the Intersection of Race and Heart Failure
  • Conclusion
  • Notes
  • Works Cited
  • Index
Tags: , ,

The Chalk Circle: Intercultural Prizewinning Essays

Posted in Anthologies, Anthropology, Asian Diaspora, Autobiography, Books, Health/Medicine/Genetics, Media Archive, Native Americans/First Nation, Religion on 2012-12-21 05:01Z by Steven

The Chalk Circle: Intercultural Prizewinning Essays

Wyatt-MacKenzie Publishing
2012-05-15
220 pages
5 x 8
Paperback ISBN: 978-1-936214-71-6

Tara L. Masih, Writer & Editor

Award-winning editor Tara L. Masih put out a call in 2007 for Intercultural Essays dealing with the subjects of “culture, race, and a sense of place.” The prizewinners are gathered for the first time in a ground-breaking anthology that explores many facets of culture not previously found under one cover. The powerful, honest, thoughtful voices—Native American, African American, Asian, European, Jewish, White—speak daringly on topics not often discussed in the open, on subjects such as racism, anti-Semitism, war, self-identity, gender, societal expectations. Their words will entertain, illuminate, take you to distant lands, and spark important discussions about our humanity, our culture, and our place within society and the natural world.

  • Winner of a 2012 Skipping Stones Honor Award
  • A Featured NewPages.com New & Noteworthy Book, February 2012
  • An Amazon Hot New Release, debuting at #2 on the essay bestseller list

Table of Contents

  • Foreword by Tara L. Masih
  • Introduction by David Mura
  • THE CHALK CIRCLE: IDENTITY, HOME, AND BORDERLANDS
    • If Grandmother Had Married a Peasant Li Miao Lovett
    • Fragments: Finding Center Sarah J. Stoner
    • Giiwe: go home Christine Stark
  • AS I AM: LETTERS OF IDENTITY
    • Bufferhood: An Autoethnography Emma Sartwell
    • Valentine and This Difficult World Tilia Klebenov Jacobs
  • THE TONGUE OF WAR: A CLASH OF CULTURES
    • Reflecting on Dragons and Angels Shanti Elke Bannwart
    • Tongue-Tied Kelly Hayes-Raitt
    • Tightrope Across the Abyss Shanti Elke Bannwart
  • THE TRAGEDY OF THE COLOR LINE
    • A Dash of Pepper in the Snow Samuel Autman
    • “Miss Otis Regrets” Mary Elizabeth Parker
    • Signatures Lyzette Wanzer
  • EYEWITNESS: AS SEEN BY ANOTHER
    • Winter Seagull Toshi Washizu
    • Itam Jeff Fearnside
    • High Tech in Gaborone M. Garrett Bauman
    • Triptych: Paradise Gretchen Brown Wright
  • THE OTHER
    • Assailing Otherness Katrina Grigg-Saito
    • Fried Locusts Kamela Jordan
    • Israel: Devour the Darling Plagues Bonnie J. Morris
  • THE CULTURE OF SELF AND SPIRIT
    • Connections Betty Jo Goddard
    • Palo del Muerte Simmons B. Buntin
  • QUESTIONS FOR DISCUSSION
    • Intercultural Considerations
    • Intercultural Connections
    • Quotation Exploration
  • About the Editor, Tara L. Masih
  • Acknowledgments
  • About the Introduction Author, David Mura
  • Index of Contributors
Tags: , , , , , , , , , , , , , , , , , , , , , ,